Evidence map›Paper›PMID 33054494›Full record

ArticleBioengineered2020

New findings in the roles of Cyclin-dependent Kinase inhibitors 2B Antisense RNA 1 (

Wei Yuan, Wei Zhang, Wei Zhang, Zhong-Bao Ruan, Li Zhu, Yu Liu, Yuan-Yuan Mi, Li-Feng Zhang

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. The Link betweenBioMed research international · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Wei YuanDepartment of Cardiology, Taizhou People's Hospital , Taizhou, China.
Wei ZhangDepartment of Infectious Disease, Taizhou People's Hospital , Taizhou, China.
Wei ZhangDepartment of Oncology, Taizhou People's Hospital , Taizhou, China.
Zhong-Bao RuanDepartment of Cardiology, Taizhou People's Hospital , Taizhou, China.
Li ZhuDepartment of Cardiology, Taizhou People's Hospital , Taizhou, China.
Yu LiuDepartment of Cardiology, The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University , Changzhou, China.ORCID 0000-0002-3803-3954
Yuan-Yuan MiDepartment of Urology, Affiliated Hospital of Jiangnan University , Wuxi, China.
Li-Feng ZhangDepartment of Urology, The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University , Changzhou, China.
Nantong University · CNChangzhou No.2 People's Hospital · CNJiangnan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The relationship between Cyclin-Dependent Kinase Inhibitors 2B Antisense RNA 1 (

Indexed as

Coronary DiseaseFemaleGene FrequencyGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMalePolymorphism, Single NucleotideRNA, Long NoncodingCDKN2B antisense RNA, humanRNA, Long NoncodingAnalysisCDKN2B-AS1Coronary heart diseaseGenetic variationVariant

Identifiers

PMID33054494
PMCPMC8291866
OpenAlexW3092899363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.